Last reviewed · How we verify
NCT04368104
Office Hysteroscopy in Women Using Progesterone-only Contraception (POC)
trial testing Darwish test (office hysteroscopic bubble suction and tubal peristalsis) in Fallopian Tube Peristalsis and Patency in 146 participants. Completed in 1 July 2023.
1 June 2023
Quick facts
| Lead sponsor | Woman's Health University Hospital, Egypt |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 146 |
| Start date | 3 August 2021 |
| Primary completion | 1 June 2023 |
| Estimated completion | 1 July 2023 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Darwish test (office hysteroscopic bubble suction and tubal peristalsis)
Conditions studied
- Fallopian Tube Peristalsis and Patency — all drugs for Fallopian Tube Peristalsis and Patency →
- Endometrial Pattern — all drugs for Endometrial Pattern →
Sponsor
Woman's Health University Hospital, Egypt
Who can join
Adults 20 to 40, female only, with Fallopian Tube Peristalsis and Patency or Endometrial Pattern. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Mechanisms of action of progesterone-only contraception (POC) include endometrial and Fallopian tubal changes without any scientific documentation. We succeeded to document proper assessment of the proximal part of the Fallopian tubes and test anatomic tubal patency as well (Darwishscope test) via hysteroscopy. This study will test endometrial pattern and Fallopian tubal status in women using progesterone-only contraception (POC) utilizing office hysteroscopy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04368104
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Woman's Health University Hospital, Egypt trials
Trials by the same sponsor.
- NCT05771922 — Implication of New High Resolution Ultrasonographic Modalities for Diagnosis of Fetal Nervous System Anomalies · recruiting
- NCT05778279 — Role of New High Resolution Ultrasonographic Modalities for Diagnosis of Fetal Nervous System Anomalies · recruiting
- NCT05734287 — The Frequency of Polycystic Ovary Syndrome Among Young Reproductive Females Presenting With Hyperandrogenism: a Mixed Co · recruiting
- NCT04357054 — Darwish Hysteroscopic Test (Hysteroscopic Bubble Suction and Tubal Peristalsis of Darwish Triad) in Myomatous Uterus · NA · unknown
- NCT04825041 — Efficacy of Hysteroscopic Bubble Test, Flow Test and Peristalsis Test. · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04368104 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Woman's Health University Hospital, Egypt
- Last refreshed: 27 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04368104.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing